AMRX logo

Amneal Pharmaceuticals, Inc. (AMRX) Net Income

Annual Net Income:

-$73.88M-$25.15M(-51.63%)
December 31, 2024

Summary

  • As of today, AMRX annual net profit is -$73.88 million, with the most recent change of -$25.15 million (-51.63%) on December 31, 2024.
  • During the last 3 years, AMRX annual net income has fallen by -$94.05 million (-466.27%).
  • AMRX annual net income is now -129.51% below its all-time high of $250.36 million, reached on December 1, 2010.

Performance

AMRX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Quarterly Net Income:

$35.61M+$10.99M(+44.65%)
June 30, 2025

Summary

  • As of today, AMRX quarterly net profit is $35.61 million, with the most recent change of +$10.99 million (+44.65%) on June 30, 2025.
  • Over the past year, AMRX quarterly net income has increased by +$18.82 million (+112.13%).
  • AMRX quarterly net income is now -72.91% below its all-time high of $131.46 million, reached on March 1, 2010.

Performance

AMRX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM Net Income:

$51.24M+$18.82M(+58.06%)
June 30, 2025

Summary

  • As of today, AMRX TTM net profit is $51.24 million, with the most recent change of +$18.82 million (+58.06%) on June 30, 2025.
  • Over the past year, AMRX TTM net income has increased by +$184.44 million (+138.47%).
  • AMRX TTM net income is now -81.44% below its all-time high of $276.13 million, reached on September 1, 2010.

Performance

AMRX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

AMRX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-51.6%+112.1%+138.5%
3Y3 Years-466.3%+114.8%+118.8%
5Y5 Years+87.8%+248.7%+381.7%

AMRX Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-466.3%+71.0%at high+138.2%at high+119.0%
5Y5-Year-207.7%+87.8%at high+114.8%-25.3%+118.8%
All-TimeAll-Time-129.5%+87.8%-72.9%+109.8%-81.4%+108.5%

AMRX Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
$35.61M(+44.7%)
$51.24M(+58.1%)
Mar 2025
-
$24.62M(+218.7%)
$32.42M(+143.9%)
Dec 2024
-$73.88M(-51.6%)
-$20.74M(-276.4%)
-$73.88M(+49.6%)
Sep 2024
-
$11.76M(-30.0%)
-$146.48M(-10.0%)
Jun 2024
-
$16.79M(+120.6%)
-$133.20M(-10.7%)
Mar 2024
-
-$81.68M(+12.5%)
-$120.31M(-146.9%)
Dec 2023
-$48.72M(+80.9%)
-$93.34M(-472.9%)
-$48.72M(-225.7%)
Sep 2023
-
$25.03M(-15.7%)
$38.76M(+241.8%)
Jun 2023
-
$29.68M(+394.1%)
$11.34M(+104.4%)
Mar 2023
-
-$10.09M(-72.3%)
-$258.42M(-1.4%)
Dec 2022
-$254.79M(-1363.2%)
-$5.86M(-145.1%)
-$254.79M(+5.4%)
Sep 2022
-
-$2.39M(+99.0%)
-$269.39M(+1.4%)
Jun 2022
-
-$240.08M(-3616.4%)
-$273.09M(>-9900.0%)
Mar 2022
-
-$6.46M(+68.4%)
-$835.00K(-104.1%)
Dec 2021
$20.17M(-70.6%)
-$20.46M(-235.8%)
$20.17M(-40.1%)
Sep 2021
-
-$6.09M(-118.9%)
$33.67M(+89.9%)
Jun 2021
-
$32.18M(+121.2%)
$17.73M(+146.2%)
Mar 2021
-
$14.54M(+308.9%)
-$38.39M(-156.0%)
Dec 2020
$68.58M(+111.4%)
-$6.96M(+68.4%)
$68.58M(+544.7%)
Sep 2020
-
-$22.03M(+8.0%)
$10.64M(+103.2%)
Jun 2020
-
-$23.94M(-119.7%)
-$330.72M(+7.4%)
Mar 2020
-
$121.52M(+287.2%)
-$357.30M(+40.8%)
Dec 2019
-$603.57M(-1049.7%)
-$64.90M(+82.1%)
-$603.57M(-8.0%)
Sep 2019
-
-$363.39M(-619.2%)
-$559.00M(-213.8%)
Jun 2019
-
-$50.53M(+59.5%)
-$178.14M(-0.4%)
Mar 2019
-
-$124.75M(-513.6%)
-$177.37M(-237.9%)
Dec 2018
-$52.50M(-3230.4%)
-$20.33M(-216.4%)
-$52.50M(-66.4%)
Sep 2018
-
$17.46M(+135.1%)
-$31.54M(+35.2%)
Jun 2018
-
-$49.75M(>-9900.0%)
-$48.66M(-3611.2%)
Mar 2018
-
$117.00K(-81.3%)
$1.39M(+9.2%)
Dec 2017
$1.68M(+100.4%)
$625.00K(+82.7%)
$1.27M(+100.5%)
Sep 2017
-
$342.00K(+13.2%)
-$278.94M(+39.2%)
Jun 2017
-
$302.00K(>+9900.0%)
-$458.62M(+0.7%)
Mar 2017
-
$0.00(+100.0%)
-$461.62M(+2.2%)
Dec 2016
-$472.03M(-1310.4%)
-
-
Dec 2016
-
-$279.58M(-55.9%)
-$472.03M(-160.8%)
Sep 2016
-
-$179.34M(-6539.7%)
-$181.02M(-631.3%)
Jun 2016
-
-$2.70M(+74.0%)
$34.07M(-2.4%)
Mar 2016
-
-$10.41M(-191.1%)
$34.92M(-10.4%)
Dec 2015
$39.00M(-32.0%)
$11.43M(-68.0%)
$39.00M(+40.8%)
Sep 2015
-
$35.76M(+2030.6%)
$27.69M(+260.9%)
Jun 2015
-
-$1.85M(+70.8%)
$7.67M(-82.8%)
Mar 2015
-
-$6.33M(-5377.5%)
$44.59M(-22.2%)
Dec 2014
$57.35M(-43.4%)
$120.00K(-99.2%)
$57.35M(+20.5%)
Sep 2014
-
$15.74M(-55.1%)
$47.61M(+50.2%)
Jun 2014
-
$35.07M(+445.9%)
$31.69M(+1313.6%)
Mar 2014
-
$6.42M(+166.8%)
$2.24M(-97.8%)
Dec 2013
$101.26M(+81.2%)
-$9.62M(-5245.6%)
$101.26M(-12.5%)
Sep 2013
-
-$180.00K(-103.2%)
$115.79M(-14.8%)
Jun 2013
-
$5.62M(-94.7%)
$135.97M(-8.7%)
Mar 2013
-
$105.44M(+2047.9%)
$148.98M(+166.6%)
Dec 2012
$55.87M
$4.91M(-75.5%)
$55.87M(-23.2%)
Sep 2012
-
$20.00M(+7.3%)
$72.80M(+4.0%)
DateAnnualQuarterlyTTM
Jun 2012
-
$18.63M(+51.1%)
$69.98M(+9.6%)
Mar 2012
-
$12.33M(-43.5%)
$63.87M(-2.3%)
Dec 2011
$65.40M(-73.9%)
$21.83M(+27.1%)
$65.40M(+16.8%)
Sep 2011
-
$17.18M(+37.2%)
$55.97M(-50.9%)
Jun 2011
-
$12.53M(-9.6%)
$113.92M(-14.2%)
Mar 2011
-
$13.86M(+11.7%)
$132.70M(-47.0%)
Dec 2010
$250.36M(+401.0%)
$12.40M(-83.5%)
$250.30M(-9.4%)
Sep 2010
-
$75.14M(+140.0%)
$276.13M(+33.0%)
Jun 2010
-
$31.31M(-76.2%)
$207.68M(+15.8%)
Mar 2010
-
$131.46M(+243.8%)
$179.39M(+257.7%)
Dec 2009
$49.97M(+167.2%)
$38.23M(+471.9%)
$50.15M(+139.1%)
Sep 2009
-
$6.68M(+121.9%)
$20.98M(+290.2%)
Jun 2009
-
$3.01M(+35.8%)
$5.38M(-73.1%)
Mar 2009
-
$2.22M(-75.5%)
$19.96M(+6.7%)
Dec 2008
$18.70M(-85.1%)
$9.06M(+201.6%)
$18.70M(+15.8%)
Sep 2008
-
-$8.91M(-150.7%)
$16.14M(-76.4%)
Jun 2008
-
$17.60M(+1732.9%)
$68.46M(-49.2%)
Mar 2008
-
$960.00K(-85.2%)
$134.65M(+6.9%)
Dec 2007
$125.92M(+1145.5%)
$6.50M(-85.0%)
$125.92M(-3.7%)
Sep 2007
-
$43.40M(-48.2%)
$130.83M(+55.4%)
Jun 2007
-
$83.79M(+1178.5%)
$84.17M(+1000.6%)
Mar 2007
-
-$7.77M(-168.1%)
-$9.35M(+22.4%)
Dec 2006
-$12.04M(-108.4%)
$11.40M(+449.8%)
-$12.04M(+48.6%)
Sep 2006
-
-$3.26M(+66.5%)
-$23.45M(-16.1%)
Jun 2006
-
-$9.72M(+7.1%)
-$20.19M(-92.9%)
Mar 2006
-
-$10.47M(-1524.1%)
-$10.47M(-994.6%)
Dec 2005
-$5.78M(+59.3%)
-
-
Sep 2004
-
$735.00K(+129.0%)
$1.17M(+136.9%)
Jun 2004
-
$321.00K(-93.8%)
-$3.17M(+45.1%)
Mar 2004
-
$5.22M(+202.2%)
-$5.78M(+59.3%)
Dec 2003
-$14.21M(+29.1%)
-$5.10M(-41.4%)
-$14.21M(-13.0%)
Sep 2003
-
-$3.61M(-58.0%)
-$12.58M(+11.3%)
Jun 2003
-
-$2.28M(+28.9%)
-$14.18M(+20.5%)
Mar 2003
-
-$3.21M(+7.4%)
-$17.83M(+11.0%)
Dec 2002
-$20.04M(+20.2%)
-$3.47M(+33.4%)
-$20.04M(+14.4%)
Sep 2002
-
-$5.21M(+12.3%)
-$23.42M(+6.2%)
Jun 2002
-
-$5.94M(-9.5%)
-$24.98M(+0.8%)
Mar 2002
-
-$5.42M(+20.9%)
-$25.19M(-0.3%)
Dec 2001
-$25.11M(-1.8%)
-$6.85M(-1.3%)
-$25.11M(-4.4%)
Sep 2001
-
-$6.77M(-10.1%)
-$24.06M(+10.6%)
Jun 2001
-
-$6.15M(-15.2%)
-$26.91M(-3.9%)
Mar 2001
-
-$5.34M(+8.0%)
-$25.91M(-3.8%)
Dec 2000
-$24.67M(-175.7%)
-$5.80M(+39.7%)
-$24.96M(-30.3%)
Sep 2000
-
-$9.62M(-86.9%)
-$19.16M(-94.8%)
Jun 2000
-
-$5.15M(-17.2%)
-$9.84M(-81.7%)
Mar 2000
-
-$4.39M(>-9900.0%)
-$5.41M(-193.8%)
Dec 1999
-$8.95M(-93.9%)
$0.00(+100.0%)
-$1.84M(+42.3%)
Sep 1999
-
-$297.00K(+59.0%)
-$3.19M(+16.2%)
Jun 1999
-
-$725.00K(+11.7%)
-$3.81M(+14.2%)
Mar 1999
-
-$821.00K(+39.3%)
-$4.45M(+3.6%)
Dec 1998
-$4.62M
-$1.35M(-47.6%)
-$4.62M(-41.4%)
Sep 1998
-
-$916.00K(+32.5%)
-$3.26M(-39.0%)
Jun 1998
-
-$1.36M(-37.3%)
-$2.35M(-137.3%)
Mar 1998
-
-$989.00K
-$989.00K

FAQ

  • What is Amneal Pharmaceuticals, Inc. annual net profit?
  • What is the all-time high annual net income for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. TTM net profit?
  • What is the all-time high TTM net income for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. TTM net income year-on-year change?

What is Amneal Pharmaceuticals, Inc. annual net profit?

The current annual net income of AMRX is -$73.88M

What is the all-time high annual net income for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high annual net profit is $250.36M

What is Amneal Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, AMRX annual net profit has changed by -$25.15M (-51.63%)

What is Amneal Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of AMRX is $35.61M

What is the all-time high quarterly net income for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high quarterly net profit is $131.46M

What is Amneal Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, AMRX quarterly net profit has changed by +$18.82M (+112.13%)

What is Amneal Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of AMRX is $51.24M

What is the all-time high TTM net income for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high TTM net profit is $276.13M

What is Amneal Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, AMRX TTM net profit has changed by +$184.44M (+138.47%)
On this page